Kubanda Cryotherapy, Inc. announced it raised $100,000 in an initial filing from an offering of $450,000

Company

Location

About

We provide the first minimally invasive treatment for benign and malignant masses in pets. By revolutionizing cryotherapy -- used in human medicine for more than 60 years -- we’re bringing human-quality care to man’s best friends. Our novel CryoNeedle system uses focused extreme cold to quickly and easily treat tumors, letting pets skip the scalpel and get back to playtime. After six years of successful research and development, including clinical trials at Johns Hopkins Hospital -- we are now launching our treatment offerings to clinics everywhere!